- Rajiv Grove, specialist registrar in plastic surgery,
- Roy Sanders, director
- RAFT Institute of Plastic Surgery, Mount Vernon Hospital, Northwood, Middlesex HA6 2RN
- Correspondence to: Mr R Grover
- Accepted 27 May 1998
The primary aims of plastic surgery are the restoration of appearance and function. This includes reconstruction after traumatic defects, congenital anomalies, and ablative surgery for malignancy, as well as surgery of the hand, breast surgery, and the field of aesthetic surgery. Considerable advances are being made as we begin to understand the biological basis for tissue regeneration, malignant neoplasia, and wound healing. The tools of the plastic surgeon now encompass the means of cellular manipulation of these biological processes.
Methods
Topics for this article were selected by reviewing the conference proceedings of the European Association of Plastic Surgeons and the American Society for Plastic and Reconstructive Surgery over the past four years. After a search of Medline, key articles relating to these topics were included.
Reconstructive flap surgery
Tissue used in reconstruction requires oxygen and nutrition to ensure its survival. A split thickness skin graft with low metabolic demands adheres to the wound bed and is initially nourished by diffusion, after which ingrowth of capillaries establishes a permanent blood supply. In wounds that are not able to support a graft by diffusion and many others that require tissues of better aesthetic and mechanical properties, reconstruction with tissue supported by its own blood supply is required. Such tissues transferred from one place to another are referred to as flaps. In the 1970s and 1980s anatomical research identified tissue units with an arterial and venous axis that allows them to be isolated or transferred. Advanced optical systems and microinstrumentation have permitted the transfer of these isolated tissue units with anastomosis of the axial blood supply at the recipient site for reconstruction.
Microsurgical free tissue transfer has become commonplace, and advances have been made in improving the benefit-risk ratio for free tissue transfer. The golden rule remains to achieve the maximum gain with the minimum risk and …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
The decline in the breast cancer incidence is 1.2% and it is not significant.
Published 10 February 2012
'twas ever thus
Published 10 February 2012
The value of historic human remains
Published 10 February 2012
In Praise of British Literature
Published 10 February 2012
Is real shared decision making possible?
Published 10 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Shared decision making: really putting patients at the centre of healthcare (7 responses)
Published 27 Jan 2012
Why legislation is necessary for my health reforms (7 responses)
Published 1 Feb 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012